Are professional soccer players at higher risk for ALS?

References

• Beretta S, Carrì MT, Beghi E, Chiò A, Ferrarese C. The sinister side of Italian soccer (Reflection & Reaction). Lancet Neurol. 2003;2:656–7.
   PubMed Web of Science ®Google Scholar
• Chiò A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128:472–6.
   PubMed Web of Science ®Google Scholar
• Belli S, Vanacore N. Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease?Eur J Epidemiol. 2005;20:237–42.
   PubMed Web of Science ®Google Scholar
• Taioli E. All causes of mortality in male professional soccer players. Eur J Publ Health. 2007;17:600–4.
   PubMed Web of Science ®Google Scholar
• Armon C. Sports and trauma in amyotrophic lateral sclerosis revisited. J Neurol Sci. 2007; 262:45–53.
   PubMed Web of Science ®Google Scholar
• Armon C. Amyotrophic lateral sclerosis and soccer: a different epidemiological approach strengthens the previous findings. J Neurol Sci. 2008;269:188–90.
   Google Scholar
• Kurland LT, Radhakrishnan K, Smith GE, Armon C, Nemetz PN. Mechanical trauma as a risk factor in classic amyotrophic lateral sclerosis: lack of epidemiological evidence. J Neurol Sci. 1992;113:133–43.
   PubMed Web of Science ®Google Scholar
• Armon C. An evidence based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22:217–28.
   PubMed Web of Science ®Google Scholar
• Pupillo E, Messina P, Logroscino G, Zoccolella S, Chiò A, Calvo A, et al; EURALS Consortium. Trauma and amyotrophic lateral sclerosis: a case-control study from a population based registry. Eur J Neurol. 2012;19:1509–17.
   PubMed Web of Science ®Google Scholar
• Chen H, Richard M, Sandler DP, Umbach DM, Kamel F. Head injury and amyotrophic lateral sclerosis. Am J Epidemiol. 2007;166:810–6.
   PubMed Web of Science ®Google Scholar
• Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G; SLALOM Group. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141–5.
   PubMed Web of Science ®Google Scholar
• McKee A, Cantu R, Nowinski C, Hedley-Whyte ET, Gavett BE, Budson AE, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repeated head injury. J Neuropathol Exp Neurol. 2009;68:709–35.
   PubMed Web of Science ®Google Scholar
• McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2010;69:918–29.
   PubMed Web of Science ®Google Scholar
• Armon C, Nelson LM. Is head trauma a risk factor for amyotrophic lateral sclerosis ? An evidence based review. Amyotroph Lateral Scler. 2012;13:351–6.
   PubMed Web of Science ®Google Scholar
• Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler. 2009;10:191–204.
   PubMed Web of Science ®Google Scholar
• McArdle A, Pattwell D, Vasilaki A, Griffiths RD, Jackson MJ. Contractile activity-induced oxidative stress: cellular origin and adaptive responses. Am J Physiol Cell Physiol. 2001;280: 621–7.
   PubMed Web of Science ®Google Scholar
• Cleveland DW, Rothstein J. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci. 2001;2:806–19.
   PubMed Web of Science ®Google Scholar
• Julien J-P. Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell. 2001;104:581–91.
   PubMed Web of Science ®Google Scholar
• Veldink JH, Bar PR, Joosten EAJ, Otten M, Wokke JHJ, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromusc Disord. 2003;13:737–43.
   PubMed Web of Science ®Google Scholar
• Liebetanz D, Hagemann K, von Lewinski F, Kahler E, Paulus W. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci. 2004;20:3115–20.
   PubMed Web of Science ®Google Scholar
• Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tamopolsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2004;29:656–62.
   PubMed Web of Science ®Google Scholar
• Veldink JH, Kalmijn S, Groeneveld GJ, Titulaer MJ, Wokke JH, van den Berg LH. Physical activity and the association with sporadic ALS. Neurology. 2005;64:241–5.
   PubMed Web of Science ®Google Scholar
• Tscholl P. The use of medication and nutritional supplements during FIFA World Cups 2002 and2006. Br J Sports Med.2008;42:725–30.
   Web of Science ®Google Scholar
• Taioli E. Use of permitted drugs in Italian professional soccer players. Br J Sports Med. 2007;41:439–41.
   PubMed Web of Science ®Google Scholar
• Bilak M, Wu L, Wang Q, Haughey N, Conant K, St. Hillaire C, et al. PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann Neurol. 2004;56:240–8.
   PubMed Web of Science ®Google Scholar
• Zhao W, Xie W, Xiao Q, Beers D, Appel S. Protective effects of an anti-inflammatory cytokine, interleukin-4, on motor neuron toxicity induced by activated microglia. J Neurochem. 2006;99:1176–87.
   PubMed Web of Science ®Google Scholar
• Popat RA, Tanner CM, van den Eeden SK, Bernstein AL, Bloch DA, Leimpeter A, et al. Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:157–63.
   PubMed Web of Science ®Google Scholar
• Qureshi M, Shui A, Dibernardo AB, Brown RH Jr, Schoenfeld DA, Cudkowicz ME. Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:369–74.
   PubMed Web of Science ®Google Scholar
• Fondell E, O’Reilly EJ, Fitzgerald KC, Falcone GJ, McCullough ML, Thun MJ, et al. Non-steroidal anti- inflammatory drugs and amyotrophic lateral sclerosis: results from five prospective cohort studies. Amyotroph Lateral Scler. 2012;13:573–9.
   PubMed Web of Science ®Google Scholar
• Abel EL. Football increases the risk for Lou Gehrig's disease, amyotrophic lateral sclerosis. Percept Mot Skills. 2007;104: 1251–4.
   PubMed Web of Science ®Google Scholar
• Italian ALS Study Group. Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure?Neurology. 1993;43:2466–70.
   PubMed Web of Science ®Google Scholar
• Tandan R, Bromberg MB, Forshew D, Fries TJ, Badger GJ, Carpenter J, et al. A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data. Neurology. 1996;47: 1220–6.
   PubMed Web of Science ®Google Scholar
• Carunchio I, Curcio L, Pieri M, Pica F, Caioli S, Viscomi MT, et al. Increased levels of p70S6 phosphorylation in the G93A mouse of amyotrophic lateral sclerosis and in valine-exposed cortical neurons in culture. Exp Neurol. 2010;226:218–30.
   PubMed Web of Science ®Google Scholar
• Contrusciere V, Paradisi S, Matteucci A, Melchiodi-Albedi F. Branched-chain amino acids induce neurotoxicity in rat cortical cultures. Neurotoxicity Res. 2010;17:392–8.
   PubMed Web of Science ®Google Scholar
• Manuel M, Heckman CJ. Stronger is not always better: could a bodybuilding dietary supplement lead to ALS?Exp Neurol. 2011;228:5–8.
   PubMed Web of Science ®Google Scholar
• Baker DH. Tolerance for branched-chain amino acids in experimental animals and humans. J Nutr. 2005;135: S1585–90.
   Web of Science ®Google Scholar
• Hutson SM, Sweatt AJ, Lanoue KF. Branched-chain amino acid metabolism: implications for establishing safe intakes. J Nutr. 2005;135:S1557–64.
   PubMed Web of Science ®Google Scholar
• McGuire V, Longstreth WT Jr, Nelson LM, Koepsell TD, Checkoway H, Morgan MS, et al. Occupational exposures and amyotrophic lateral sclerosis: a population based case-control study. Am J Epidemiol. 1997;145:1076–88.
   PubMed Web of Science ®Google Scholar
• Govoni V, Granieri E, Fallica E, Casetta I. Amyotrophic lateral sclerosis, rural environment and agricultural work in the local health district of Ferrare, Italy, in the years 1964 − 1998. J Neurol. 2005;252:1322–7.
   PubMed Web of Science ®Google Scholar
• Park RM, Schulte PA, Bowman JD, Walker JT, Bondy SC, Yost MG, et al. Potential occupational risk for neurodegenerative diseases. Am J Ind Med. 2005;48:63–77.
   PubMed Web of Science ®Google Scholar
• Qureshi MM, Hayden D, Urbinelli L, Ferrante K, Newhall K, Myers D, et al. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler. 2006;7:173–82.
   PubMed Web of Science ®Google Scholar
• Morahan JM, Pamphlett R. Amyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case-control study. Neuroepidemiology. 2006;27:130–5.
   PubMed Web of Science ®Google Scholar
• Furby A, Beauvais K, Kolev I, Rivain JG, Sebille V. Rural environment and risk factors of amyotrophic lateral sclerosis: a case-control study. J Neurol. 2010;257:792–8.
   PubMed Web of Science ®Google Scholar
• Bonvicini F, Marcello N, Mandrioli J, Pietrini V, Vinceti M. Exposure to pesticides and risk of amyotrophic lateral sclerosis: a population based case-control study. Ann Ist Super Sanita. 2010;46:284–7.
   PubMed Web of Science ®Google Scholar
• Wills AM, Cronin S, Sloweik A, Kasperaviciute D, van Es MA, Morahan JM, et al. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology. 2008;73:16–24.
   Web of Science ®Google Scholar
• Sutedja NA, Fischer K, Veldink JH, van der Heijden GJ, Kromhout H, Heederik D, et al. What we truly know about occupation as a risk factor for ALS: a critical and systematic review. Amyotroph Lateral Scler. 2009;10:295–301.
   PubMed Web of Science ®Google Scholar
• Sutedja NA, Veldink JH, Fisher K, Kromhout H, Heederik D, Huisman MH, et al. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler. 2009;10:302–9.
   PubMed Web of Science ®Google Scholar
• Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired national Football League players. Neurology. 2012;79:1970–4.
   PubMed Web of Science ®Google Scholar
• Chiò A, Calvo A, Dossena M, Ghiglione P, Mutani R, Mora G. ALS is Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009;10:205–9.
   PubMed Web of Science ®Google Scholar
• Wicks P, Ganesalingham J, Collin C, Prevett M, Leigh NP, Al-Chalabi A. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:177–9.
   PubMed Web of Science ®Google Scholar
• Mattsson P, Lönnstedt I, Nygren I, Askmark H. Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early age. J Neurol Neurosurg Psychiatry. 2010;83:390–4.
   PubMed Web of Science ®Google Scholar
• Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and university athletics in ALS. Neurology. 2002;59:773–5.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Leigh PN. Trouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis?Brain. 2005;128:451–3.
   PubMed Web of Science ®Google Scholar
• Holden C. Peering under the hood of Africa's runners. Science. 2004;305:637–9.
   PubMed Web of Science ®Google Scholar
• Le Galliard JF, Clobert J, Ferriere R. Physical performance and Darwinian fitness in lizards. Nature. 2004;432:502–5.
   PubMed Web of Science ®Google Scholar
• Vivekananda U, Manjalay Z, Ganesalingam J, Simms J, Shaw CE, Leigh PN, et al. Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. J Neurol Neurosurg Psychiatry. 2011;82:635–7.
   PubMed Web of Science ®Google Scholar
• Manning JT, Fink B. Digit ratio (2D:4D), dominance, reproductive success, asymmetry, and sociosexuality in the BBC Internet Study. Am J Hum Biol. 2008;20:451–61.
   PubMed Web of Science ®Google Scholar
• Hönekopp J, Schuster M. A meta-analysis on 2D:4D and athletic prowess: substantial relationships but neither hand out-predicts the other. Pers Indiv Differ. 2010;48:4–10.
   Web of Science ®Google Scholar
• Tester N, Campbell A. Sporting achievement: what is the contribution of digit ratio?J Pers. 2007;75:663–78.
   PubMed Web of Science ®Google Scholar
• Manning JT, Morris L, Caswell N. Endurance running and digit ratio (2D: 4D): implications for foetal testosterone effects on running speed and vascular health. Am J Hum Biol. 2007;19:416–21.
   PubMed Web of Science ®Google Scholar
• Turner MR, Wotton C, Talbot K, Goldacre MJ. Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry. 2012;83:395–8.
   PubMed Web of Science ®Google Scholar
• Huisman MHB, de Jong DW, Verwijs MC, Schelhass HJ, van der Kooi AJ, de Visser M, et al. Family history of neurodegenerative and vascular diseases in ALS, a population based study. Neurology. 2011;77:1363–9.
   PubMed Web of Science ®Google Scholar
• Beghi E. 127th ENMC International Workshop: implementation of a European registry of ALS. Naarden, The Netherlands, 8 − 10 October 2004. Neuromuscul Disord. 2006;16:46–53.
   PubMedGoogle Scholar